Home / NYT / Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.

Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.

Technology


By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year. Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year. Reviewed by Virual stuff on January 25, 2022 Rating: 5

Ad Home

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.